Puma Biotechnology
PBYI
PBYI
141 hedge funds and large institutions have $715M invested in Puma Biotechnology in 2018 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 45 increasing their positions, 48 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 43
48% less call options, than puts
Call options by funds: $5.87M | Put options by funds: $11.2M
56% less capital invested
Capital invested by funds: $1.64B → $715M (-$925M)
Holders
141
Holding in Top 10
2
Calls
$5.87M
Puts
$11.2M
Top Buyers
| 1 | +$29.3M | |
| 2 | +$28.1M | |
| 3 | +$27.3M | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$23.6M |
| 5 |
Millennium Management
New York
|
+$21.8M |
Top Sellers
| 1 | -$106M | |
| 2 | -$84.9M | |
| 3 | -$52.8M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$28.8M |
| 5 |
Jennison Associates
New York
|
-$22.4M |